News
AbbVie Inc. (NYSE:ABBV) is one of those businesses where I expressed slightly different opinions in different articles over the years and while this might...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Investing in high-growth opportunities across industries, employing a value investing approach that prioritizes robust business models and strategic...
News
This article was written by Follow I’m a full time value investor and writer who enjoys using classical value ratios to pick my portfolio....
News
This article was written by Follow Buffett-style rational value picks | Top 95th percentile of financial bloggers according to TipRanks.Six years of long-horizon investment...
News
The 2023 Mazda3 compact car offers choices of body styles, engines, and the option of all-wheel drive. This is one of the most enjoyable...
News
Most major government bond markets experienced sell-offs for the second straight month in June, with yields on 10-year benchmark bonds from the UK to...
News
Lawsuits are just part and parcel of being a company with a twelve-figure market capitalization. Or even just a ten-figure market cap. Still, the...
News
Shopify’s (NYSE:SHOP) stock has moved higher in recent months on the back of stable growth and the abandonment of its capital-intensive logistics initiative. The...
News
There’s an old maxim, “the secret to happiness is low expectations.” This saying could not apply more directly than to what we are seeing...
News
By James Smith, Developed Markets Economist Some good news on inflation for once If you’re looking for some good news on the UK inflation...
News
A few months ago, I wrote a cautious article on the Hoya Capital High Dividend Yield ETF (RIET). While RIET’s 10% distribution yield was...
News
Investment thesis Our current investment thesis is: JHG has struggled with growth, as investors are increasingly unconvinced by the value offered by active management....
News
Introduction ImmunoGen (NASDAQ:IMGN) is a commercial-stage biotech firm focused on developing innovative antibody-drug conjugates (ADCs) to enhance cancer treatment. These targeted therapies boast improved...
